This is one of the few human clinical data points for BPC-157 and, while small, it supports the direction of the preclinical work
CNS and GI Motility Medications GLP-1 interactions with CNS and GI medications often require a personalized approach
Enter Copper Peptides (specifically known as GHK-Cu)
Efficacy and safety of lixisenatide once daily versus placebo in type 2 diabetes insufficiently controlled on pioglitazone (getgoal-P)
Thats core to The Medi Difference: we combine your GLP-1 with a personalized nutrition plan, muscle preservation protocols, signature supplements, and in-person coaching
manufacturing investment, including a new fill-and-finish facility in Clayton, North Carolina, targeted to add 600 million additional Wegovy pen doses annually by 2027